Loading ...

PA-PEG1k-RGD/pshVEGF nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

cyclic RGDfC peptide conjugated with PAM-ABP

RGD-conjugated PAM-ABP PA-PEG1k-RGD
Type Polymer
Formula
Role raw materials
2

human VEGF siRNA expressing plasmid

human VEGF siRNA expressing pDNA pshVEGF
Type Biomolecule
Formula
Role raw materials

Properties

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
human breast cancer MCF7 cells

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • human VEGF siRNA expressing plasmid
  • cyclic RGDfC peptide conjugated with PAM-ABP
  1. RssTqQAp
Product

PA-PEG1k-RGD/pshVEGF nanoparticles

Size: not specified

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial